Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0362	EEF1A1P9	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0445	ENST00000318333	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0446	RPL12P1	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0451	POM121L13P	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	down-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0458	MTCO3P10	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0459	AL133244.1	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0460	AC096915.1	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0477	EPOR	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	down-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL0556	H19	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	H19 expression level was 4.97 to 13.58-fold higher in GCa samples than the mean level in paired non-cancerous tissues. Moreover, the expression levels of H19 were increased significantly in the tumors of patients with advanced clinical stage (p < 0.001) and larger tumor size ( p < 0.001).	24414129	Lnc2Cancer
EL0578	HOTAIR	gastric cardia adenocarcinoma	PCR-RFLP, qPCR etc.	blood	up-regulated	mutation	Among three htSNPs of the HOTAIR gene (rs12826786 C>T, rs4759314 A>G, and rs10783618 C>T), only the T allele of rs12826786 was found to increase the risk of developing GCA and was associated with smoking habit and tumor-node-metastasis (TNM) stage. In addition, higher expression levels of HOTAIR were found in tumor tissues and rs12826786 SNP has a genotype-specific effetc on HOTAIR expression. A high HOTAIR expression level was associated with poor GCA patients' survival.	25476857	Lnc2Cancer
EL0703	LINC01550	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	down-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL1074	PMS2P5	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL1270	TCF7	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	down-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer
EL1423	uc003jfz.2	gastric cardia adenocarcinoma	microarray, qPCR etc.	gastric cancer tissue	up-regulated	N/A	We found that ASHG19A3A029791, ASHG19A3A034382, ASHG19A3A028003, ASHG19A3A013479, ASHG19A3A022744, ASHG19A3A025864, ASHG19A3A043106 and ASHG19A3A03455, were up-regulated, and ASHG19A3A007791, ASHG19A3A050006, ASHG19A3A051125, ASHG19A3A011053 were down-regulated in the GCa samples compared with normal samples. Thus, the results from the qPCR analysis and the microarray data analysis were consistent (p < 0.05).	24414129	Lnc2Cancer